Filter Results

Clinical Studies


  • MC1924: SBRT with Immunotherapy for Mesothelioma (MC1924) Rochester, Minn.

    The purpose of this study is to evaluate whether adding stereotactic body radiation therapy (SBRT) to immunotherapy as part of second line treatment for mesothelioma will improve the modest response rate of immunotherapy alone, provide local control/cytoreduction to sites of gross disease, and decrease symptomatic burden while improving outcomes.